Health Condition 1: Z128- Encounter for screening for malignant neoplasm of other sites
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of Stage IV OSMF according to Khanna and Andrade classification (1995)30. Patients in age group 20-50 years. Patient willing for cessation of habit
Exclusion criteria
Exclusion criteria: Temporomandibular joint disorder or trauma to it. Patient giving history of allergy to placentrex injection . Clinical signs and symptoms or proven report of malignancy and red and white lesion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the efficacy of autologous platelet-rich plasma and Placentrex in combination with hyaluronidase for improving mouth opening in oral submucous fibrosis following immediate surgical release of fibrous bands for 3 months.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate and compare the efficacy of autologous platelet-rich plasma and Placentrex in combination with hyaluronidase for reducing burning sensation and increasing cheek flexibility in oral submucous fibrosis following immediate surgical release of fibrous bands for 3 months.Timepoint: 3 months | — |
Countries
India
Contacts
Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital